CN117298328B - 一种医用粘合剂 - Google Patents
一种医用粘合剂 Download PDFInfo
- Publication number
- CN117298328B CN117298328B CN202311626656.XA CN202311626656A CN117298328B CN 117298328 B CN117298328 B CN 117298328B CN 202311626656 A CN202311626656 A CN 202311626656A CN 117298328 B CN117298328 B CN 117298328B
- Authority
- CN
- China
- Prior art keywords
- weight
- butyl
- cyanoacrylate
- alpha
- medical adhesive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001070 adhesive effect Effects 0.000 title claims abstract description 70
- 239000000853 adhesive Substances 0.000 title claims abstract description 68
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims description 53
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 claims description 48
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 32
- 229950010048 enbucrilate Drugs 0.000 claims description 32
- JJJFUHOGVZWXNQ-UHFFFAOYSA-N enbucrilate Chemical compound CCCCOC(=O)C(=C)C#N JJJFUHOGVZWXNQ-UHFFFAOYSA-N 0.000 claims description 24
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims description 18
- 229920006217 cellulose acetate butyrate Polymers 0.000 claims description 17
- 229920001651 Cyanoacrylate Polymers 0.000 claims description 16
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 claims description 16
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 16
- 239000001069 triethyl citrate Substances 0.000 claims description 16
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 claims description 16
- 235000013769 triethyl citrate Nutrition 0.000 claims description 16
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 230000004927 fusion Effects 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000002562 thickening agent Substances 0.000 abstract description 27
- 238000006116 polymerization reaction Methods 0.000 abstract description 25
- 239000002253 acid Substances 0.000 abstract description 20
- 239000004014 plasticizer Substances 0.000 abstract description 20
- 239000003381 stabilizer Substances 0.000 abstract description 15
- 239000003963 antioxidant agent Substances 0.000 abstract description 13
- 239000003112 inhibitor Substances 0.000 abstract description 13
- 230000003078 antioxidant effect Effects 0.000 abstract description 11
- -1 tackifier Substances 0.000 abstract description 4
- 239000012567 medical material Substances 0.000 abstract description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 33
- 230000000052 comparative effect Effects 0.000 description 31
- 238000000034 method Methods 0.000 description 17
- 239000007789 gas Substances 0.000 description 16
- 235000006708 antioxidants Nutrition 0.000 description 11
- 230000000694 effects Effects 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- IJVRPNIWWODHHA-UHFFFAOYSA-N 2-cyanoprop-2-enoic acid Chemical compound OC(=O)C(=C)C#N IJVRPNIWWODHHA-UHFFFAOYSA-N 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000000178 monomer Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 4
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 4
- NIQCNGHVCWTJSM-UHFFFAOYSA-N Dimethyl phthalate Chemical compound COC(=O)C1=CC=CC=C1C(=O)OC NIQCNGHVCWTJSM-UHFFFAOYSA-N 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- ZFOZVQLOBQUTQQ-UHFFFAOYSA-N Tributyl citrate Chemical compound CCCCOC(=O)CC(O)(C(=O)OCCCC)CC(=O)OCCCC ZFOZVQLOBQUTQQ-UHFFFAOYSA-N 0.000 description 4
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 4
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 4
- ALOUNLDAKADEEB-UHFFFAOYSA-N dimethyl sebacate Chemical compound COC(=O)CCCCCCCCC(=O)OC ALOUNLDAKADEEB-UHFFFAOYSA-N 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010067484 Adverse reaction Diseases 0.000 description 3
- 241001391944 Commicarpus scandens Species 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 230000006838 adverse reaction Effects 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- FGBJXOREULPLGL-UHFFFAOYSA-N ethyl cyanoacrylate Chemical compound CCOC(=O)C(=C)C#N FGBJXOREULPLGL-UHFFFAOYSA-N 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000007711 solidification Methods 0.000 description 3
- 230000008023 solidification Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 description 2
- IWYVYUZADLIDEY-UHFFFAOYSA-N 4-methoxybenzenesulfonic acid Chemical compound COC1=CC=C(S(O)(=O)=O)C=C1 IWYVYUZADLIDEY-UHFFFAOYSA-N 0.000 description 2
- XESZUVZBAMCAEJ-UHFFFAOYSA-N 4-tert-butylcatechol Chemical compound CC(C)(C)C1=CC=C(O)C(O)=C1 XESZUVZBAMCAEJ-UHFFFAOYSA-N 0.000 description 2
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 229910015900 BF3 Inorganic materials 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- 208000005189 Embolism Diseases 0.000 description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 2
- 229920001730 Moisture cure polyurethane Polymers 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 206010046996 Varicose vein Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000004026 adhesive bonding Methods 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 229960004106 citric acid Drugs 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- FBSAITBEAPNWJG-UHFFFAOYSA-N dimethyl phthalate Natural products CC(=O)OC1=CC=CC=C1OC(C)=O FBSAITBEAPNWJG-UHFFFAOYSA-N 0.000 description 2
- 229940014772 dimethyl sebacate Drugs 0.000 description 2
- 229960001826 dimethylphthalate Drugs 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 230000003073 embolic effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 2
- RPQUGMLCZLGZTG-UHFFFAOYSA-N octyl cyanoacrylate Chemical compound CCCCCCCCOC(=O)C(=C)C#N RPQUGMLCZLGZTG-UHFFFAOYSA-N 0.000 description 2
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 2
- 238000011056 performance test Methods 0.000 description 2
- JQCXWCOOWVGKMT-UHFFFAOYSA-N phthalic acid diheptyl ester Natural products CCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCC JQCXWCOOWVGKMT-UHFFFAOYSA-N 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- 235000002949 phytic acid Nutrition 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 229920002689 polyvinyl acetate Polymers 0.000 description 2
- 239000011118 polyvinyl acetate Substances 0.000 description 2
- 230000027756 respiratory electron transport chain Effects 0.000 description 2
- 239000003106 tissue adhesive Substances 0.000 description 2
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 2
- 208000027185 varicose disease Diseases 0.000 description 2
- 210000002073 venous valve Anatomy 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- 229920002724 Poly(ethyl cyanoacrylate) Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 206010053648 Vascular occlusion Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010539 anionic addition polymerization reaction Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 229940053009 ethyl cyanoacrylate Drugs 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000000687 hydroquinonyl group Chemical group C1(O)=C(C=C(O)C=C1)* 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 239000002120 nanofilm Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- ZTYMNUBYYQNBFP-UHFFFAOYSA-N propyl 2-cyanoprop-2-enoate Chemical compound CCCOC(=O)C(=C)C#N ZTYMNUBYYQNBFP-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000021331 vascular occlusion disease Diseases 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Materials For Medical Uses (AREA)
- Adhesives Or Adhesive Processes (AREA)
Abstract
Description
组分 | 实施例1 | 实施例2 | 实施例3 | 对比例1 | 对比例2 | 对比例3 |
α-氰基丙烯酸正丁酯(%) | 55.953 | 60.108 | 45.513 | 55.353 | 65.353 | 72.353 |
柠檬酸三乙酯(%) | 35 | 25 | 40 | 37.6 | 27.6 | 20.6 |
磷酸(‰) | 0.03 | 0.01 | 0.05 | 0.03 | 0.03 | 0.03 |
醋酸丁酸纤维素(%) | 7 | 5 | 10 | 7 | 7 | 7 |
聚α-氰基丙烯酸正丁酯(%) | 2.0 | 9.8 | 4.4 | / | / | / |
丁基羟基苯甲醚(%) | 0.01 | 0.08 | 0.05 | 0.01 | 0.01 | 0.01 |
二氧化硫(‰) | 0.04 | 0.01 | 0.02 | 0.04 | 0.04 | 0.04 |
对苯二酚(%) | 0.03 | 0.01 | 0.03 | 0.03 | 0.03 | 0.03 |
组分 | 实施例1 | 实施例2 | 实施例3 | 对比例1 | 对比例2 | 对比例3 |
粘度(cp) | 1861 | 1958 | 2126 | 3911 | 1618 | 1324 |
固化时间 | 3分5秒 | 3分51秒 | 9分42秒 | 6分53秒 | 1分48秒 | 46秒 |
韧性 | 强 | 强 | 差 | 中 | 中 | 差 |
搭接强度(N)5mm/min | 19.4 | 14.2 | 5.2 | 17.1 | 24.0 | 25.9 |
剥离强度(N)50mm/min | 2.87 | 2.28 | 0.12 | 2.30 | 2.54 | 4.50 |
甲醛释放量(ug/ml) | 31 | 33 | 15 | 36 | 40 | 45 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311626656.XA CN117298328B (zh) | 2023-11-30 | 2023-11-30 | 一种医用粘合剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311626656.XA CN117298328B (zh) | 2023-11-30 | 2023-11-30 | 一种医用粘合剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN117298328A CN117298328A (zh) | 2023-12-29 |
CN117298328B true CN117298328B (zh) | 2024-03-08 |
Family
ID=89288772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311626656.XA Active CN117298328B (zh) | 2023-11-30 | 2023-11-30 | 一种医用粘合剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117298328B (zh) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01101383A (ja) * | 1987-10-15 | 1989-04-19 | Aikoo Kk | シアノ系接着剤組成物 |
CN101987081A (zh) * | 2010-07-16 | 2011-03-23 | 钟术光 | 一种控释制剂 |
CN104958781A (zh) * | 2015-07-29 | 2015-10-07 | 陕西博与再生医学有限公司 | 一种化学医用粘合剂组合物及其制备方法 |
CN105199285A (zh) * | 2015-11-12 | 2015-12-30 | 三友(天津)高分子技术有限公司 | 一种增韧的氰基丙烯酸酯组合物 |
CN113679876A (zh) * | 2021-08-13 | 2021-11-23 | 上海恩盛医疗科技有限公司 | 一种医用软组织粘合剂及其制备方法 |
CN114796591A (zh) * | 2022-06-06 | 2022-07-29 | 北京康派特医疗器械有限公司 | 一种氰基丙烯酸酯类医用胶及其制备方法和用途 |
CN115054723A (zh) * | 2022-08-19 | 2022-09-16 | 苏州美创医疗科技有限公司 | 一种具有柔韧性的粘合剂 |
CN115715822A (zh) * | 2022-12-06 | 2023-02-28 | 上海馥留材料科技有限公司 | 一种医用软组织粘合胶及其制备方法和应用 |
CN116059435A (zh) * | 2023-02-14 | 2023-05-05 | 浙江伽奈维医疗科技有限公司 | 一种用于小血管栓塞的粘合剂及其制备方法 |
CN116159177A (zh) * | 2023-02-02 | 2023-05-26 | 浙江伽奈维医疗科技有限公司 | 一种用于治疗大隐静脉曲张的粘合剂及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101206848B1 (ko) * | 2010-11-02 | 2012-12-03 | (주)인튜이티브메디코프 | 시아노아크릴레이트계 생체 접착제 조성물 |
US9839717B2 (en) * | 2015-09-10 | 2017-12-12 | Fa-Ter CHU | Cyanoacrylate adhesive composition and method for making the same |
-
2023
- 2023-11-30 CN CN202311626656.XA patent/CN117298328B/zh active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01101383A (ja) * | 1987-10-15 | 1989-04-19 | Aikoo Kk | シアノ系接着剤組成物 |
CN101987081A (zh) * | 2010-07-16 | 2011-03-23 | 钟术光 | 一种控释制剂 |
CN104958781A (zh) * | 2015-07-29 | 2015-10-07 | 陕西博与再生医学有限公司 | 一种化学医用粘合剂组合物及其制备方法 |
CN105199285A (zh) * | 2015-11-12 | 2015-12-30 | 三友(天津)高分子技术有限公司 | 一种增韧的氰基丙烯酸酯组合物 |
CN113679876A (zh) * | 2021-08-13 | 2021-11-23 | 上海恩盛医疗科技有限公司 | 一种医用软组织粘合剂及其制备方法 |
CN114796591A (zh) * | 2022-06-06 | 2022-07-29 | 北京康派特医疗器械有限公司 | 一种氰基丙烯酸酯类医用胶及其制备方法和用途 |
CN115054723A (zh) * | 2022-08-19 | 2022-09-16 | 苏州美创医疗科技有限公司 | 一种具有柔韧性的粘合剂 |
CN115715822A (zh) * | 2022-12-06 | 2023-02-28 | 上海馥留材料科技有限公司 | 一种医用软组织粘合胶及其制备方法和应用 |
CN116159177A (zh) * | 2023-02-02 | 2023-05-26 | 浙江伽奈维医疗科技有限公司 | 一种用于治疗大隐静脉曲张的粘合剂及其制备方法 |
CN116059435A (zh) * | 2023-02-14 | 2023-05-05 | 浙江伽奈维医疗科技有限公司 | 一种用于小血管栓塞的粘合剂及其制备方法 |
Non-Patent Citations (4)
Title |
---|
丙烯酸酯胶粘剂研究进展;熊林, 王建营, 延玺, 胡文祥;中国胶粘剂;20020530(第03期);49-54页 * |
医用α-氰基丙烯酸酯的研究进展;张飞;孟兴凯;雷艳秋;武隽忞;陈敬龙;;内蒙古医学院学报(第S2期);126-129页 * |
张振英等编著.《塑料、橡胶用胶粘剂》.北京:中国石化出版社,2004,第167-168页. * |
彭安顺等主编.《精细有机品化学》.东营:石油大学出版社,1996,第185-186页. * |
Also Published As
Publication number | Publication date |
---|---|
CN117298328A (zh) | 2023-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6476069B2 (en) | Compositions for creating embolic agents and uses thereof | |
Zhang et al. | Mussel-inspired hyperbranched poly (amino ester) polymer as strong wet tissue adhesive | |
EP3335738B1 (en) | New type cyanoacrylate medical adhesive and preparation method and use thereof | |
US5614204A (en) | Angiographic vascular occlusion agents and a method for hemostatic occlusion | |
KR101474085B1 (ko) | 연조직용 접착제 조성물, 창상 피복용 접착제 조성물 또는 창상 피복제 조성물 | |
US20140222067A1 (en) | Minimally invasive surgery, including vascular closure, and associated sealants | |
CN104958781A (zh) | 一种化学医用粘合剂组合物及其制备方法 | |
CN115054723B (zh) | 一种具有柔韧性的粘合剂 | |
CN117298328B (zh) | 一种医用粘合剂 | |
Kiemeneij et al. | Improved anticoagulation management after Palmaz Schatz coronary stent implantation by sealing the arterial puncture site with a vascular hemostasis device | |
CN117503985A (zh) | 一种医用软组织粘合胶及其制备方法和应用 | |
CN114796591A (zh) | 一种氰基丙烯酸酯类医用胶及其制备方法和用途 | |
CN113861451A (zh) | 一种生物医用组织粘合剂的制备方法 | |
CN115109367A (zh) | 一种可注射水凝胶及其制备方法与应用 | |
CN105477679B (zh) | 基于多糖交联的壳聚糖快速止血棉 | |
CN106075543B (zh) | 一种可吸收止血结扎夹及其制备方法 | |
CN115518191B (zh) | 一种可以促进伤口快速止血的医用敷料的制备方法 | |
CN115006584B (zh) | 一种皮肤创面修复粘合剂 | |
EP2596813B1 (en) | Sheet preparation for tissue adhesion | |
CN114796590A (zh) | 一种自增粘型氰基丙烯酸酯医用胶及其制备方法 | |
CN112155625A (zh) | 一种载药可降解血管吻合器 | |
CN117717645A (zh) | 一种适合终端灭菌的静脉粘合剂及其制备方法 | |
CN116726233A (zh) | 一种用于胃静脉血管栓塞的胶粘剂及其制备方法 | |
WO2015014540A1 (en) | Improved cyanoacrylate compositions | |
CN115887739A (zh) | 一种医用粘合剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240718 Address after: 200120, 3rd Floor, Building 36, No. 356 Zhengbo Road, Lingang New Area, Pudong New Area, Shanghai Patentee after: Shanghai rongmai Medical Technology Co.,Ltd. Country or region after: China Address before: No. 1, 34th Floor, Building 2, No. 88 Jitai Fifth Road, High tech Zone, Chengdu, Sichuan, 610000 Patentee before: Sichuan Guoyi Medical Technology Co.,Ltd. Country or region before: China Patentee before: Shanghai rongmai Medical Technology Co.,Ltd. |